Central nervous system blockade by peripheral administration of AT1 receptor blockers.
about
The cardiovascular response of normal rats to dual lesion of the subfornical organ and area postrema at rest and to chronic losartanCirculating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier.Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra.Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders.Distinct effects of intravascular and extravascular angiotensin II on cerebrovascular circulation of newborn pigsAngiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.Sympathoexcitation associated with Renin-Angiotensin system in metabolic syndrome.Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure?Pharmacological treatment for heart failure: a view from the brain.Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension.Regulation of the sympathetic nervous system by nitric oxide and oxidative stress in the rostral ventrolateral medulla: 2012 Academic Conference Award from the Japanese Society of Hypertension.Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.Should losartan be administered following brain injury?Angiotensin II centrally induces frequent detrusor contractility of the bladder by acting on brain angiotensin II type 1 receptors in rats.CB1 receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission.Update on angiotensin II: new endocrine connections between the brain, adrenal glands and the cardiovascular system.Involvement of Type 1 Angiontensin II Receptor (AT1) in Cardiovascular Changes Induced by Chronic Emotional Stress: Comparison between Homotypic and Heterotypic Stressors.Oxidative stress in the brain causes hypertension via sympathoexcitation.Telmisartan Activates PPARδ to Improve Symptoms of Unpredictable Chronic Mild Stress-Induced Depression in Mice.Inhibition of the renin-angiotensin system prevents seizures in a rat model of epilepsy.Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.Interactions between angiotensin AT1 receptor antagonists and second-generation antiepileptic drugs in the test of maximal electroshock.Chronic central versus systemic blockade of AT(1) receptors and cardiac dysfunction in rats post-myocardial infarction.Valsartan abolishes most of the memory-improving effects of intracerebroventricular angiotensin II in rats.Hypothalamic dysfunction in heart failure: pathogenetic mechanisms and therapeutic implications.Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats.Sympathoinhibition caused by orally administered telmisartan through inhibition of the AT₁ receptor in the rostral ventrolateral medulla of hypertensive rats.Combination therapy of olmesartan and azelnidipine inhibits sympathetic activity associated with reducing oxidative stress in the brain of hypertensive rats.Central and peripheral renin-angiotensin systems in ouabain-induced hypertension.Angiotensin II AT1 receptor blockade by telmisartan reduces impairment of spatial maze performance induced by both acute and chronic stress.Effects of stress on behavior and resting-state fMRI in rats and evaluation of Telmisartan therapy in a stress-induced depression model
P2860
Q33649637-5A4010B3-E7ED-4989-B437-5ACEA8370068Q33842137-218FB798-987B-480E-91F5-F1DA5B6EE889Q35613025-85296ED7-7586-4638-85E3-E82D3E01B095Q35827935-A00EF72A-B57F-43D3-AB13-3FCA1AF666E8Q36229368-4ABCFEF3-1BCF-460C-8B57-C2D73731C050Q36410269-CEED5CC7-4297-4135-9635-4D241EA551B6Q36651383-3D1CE0F3-E8DE-4F68-B522-0BADB575702CQ37465538-E9AEF992-CAB9-4C2B-8586-F64CA57881BFQ37530428-6B761A0E-E2CB-4E7F-9842-920F34387392Q37846532-606881D3-F2CC-4AD9-828F-A6DAA04A79C8Q38122303-FC01B5B3-EF9D-4FF5-A1C6-2DC2BD98A7A0Q38191484-7E93D60C-9902-4B66-BDF5-F8773194806DQ38262865-6330DC5A-F8C7-4527-A0B0-61BEC65BA44BQ38608090-AA4A872F-205D-4C61-AF3C-F8E0E838AC73Q40448573-618F5F69-FC79-4C84-B663-3729BA1E9C08Q41664884-BC38E94E-A527-4469-A5F3-BAE304099CB8Q41697456-BB740675-F4BD-43C9-A54C-7DD08D0F9B5AQ41943162-F771F6D6-CAFD-4C91-A60B-69DC5A3D4EC5Q42630308-370EE6C7-4FC6-47DC-9953-B9FA51B80DCDQ43038118-B30175CD-D2AA-4B47-AB87-0BE3DDBAC527Q43274970-6D12BD66-1BA0-4611-A4CF-F545FD3FAEB7Q45132932-C30EBAD0-5AEF-4E67-B5AE-5829C7DEF3C5Q45925566-1A0F2F91-B7EB-40A5-8157-37CC466A7279Q46816577-3DE715AC-0812-4AC7-AED6-41B15C65BAFBQ47733807-7128DB7C-FA7E-47F4-92B4-05B3B76070C1Q48107212-27799324-6BD5-4B64-A115-064B390E3B80Q48521760-564EEB1E-DB67-4316-9FCF-D1D88E36D36BQ48586155-C476A628-3C6F-4D64-B1DB-7D852ED66FAEQ48604634-63C9C026-F1F5-4DAB-B02D-159F00ADC58AQ50679658-B2D90B81-1268-45C7-A3E3-FCCE5C56533FQ58605296-5888628F-AC3F-4D8B-B96F-553B20027026
P2860
Central nervous system blockade by peripheral administration of AT1 receptor blockers.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Central nervous system blockade by peripheral administration of AT1 receptor blockers.
@en
Central nervous system blockade by peripheral administration of AT1 receptor blockers.
@nl
type
label
Central nervous system blockade by peripheral administration of AT1 receptor blockers.
@en
Central nervous system blockade by peripheral administration of AT1 receptor blockers.
@nl
prefLabel
Central nervous system blockade by peripheral administration of AT1 receptor blockers.
@en
Central nervous system blockade by peripheral administration of AT1 receptor blockers.
@nl
P2093
P1476
Central nervous system blockade by peripheral administration of AT1 receptor blockers.
@en
P2093
Frans H H Leenen
Jun Ming Wang
Junhui Tan
P304
P356
10.1097/00005344-200304000-00012
P577
2003-04-01T00:00:00Z